July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Effect of SOX2 Repression on Corneal Endothelial Cells
Author Affiliations & Notes
  • Hochul Yi
    Ophthalmology, Hallym University College of Medicine, Seoul, Korea (the Republic of)
  • Young Joo Shin
    Ophthalmology, Hallym University College of Medicine, Seoul, Korea (the Republic of)
  • Jin Sun Hwang
    Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (the Republic of)
  • Tae-Young Chung
    Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships   Hochul Yi, None; Young Joo Shin, None; Jin Sun Hwang, None; Tae-Young Chung, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 5110. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hochul Yi, Young Joo Shin, Jin Sun Hwang, Tae-Young Chung; Effect of SOX2 Repression on Corneal Endothelial Cells. Invest. Ophthalmol. Vis. Sci. 2019;60(9):5110.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the effect of SOX2 repression on human corneal endothelial cells (HCECs).

Methods : Cultured HCECs were transfected by siRNA for SOX2. Cell viability and cell proliferation rate were measured. Cell proliferation-associated protein expression was evaluated by western blotting and RT-PCR. Cell shape and WNT signaling was assessed.

Results : SOX2 expression was reduced 80% by siRNA for SOX2. Cell viability and proliferation rate was reduced. CDK and cyclin D1 expression reduced and CDKN2A expression increased. SIRT1 and ATP5B expression were reduced and pAMPK expression was elevated. Cell shape became elongated by siRNA for SOX2. WNT3A and β-catenin expression increased by siRNA for SOX2.

Conclusions : SOX2 repression may disrupt the normal wound healing process of HCECs. SOX2 may be a molecular target for corneal regeneration.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×